Contents
- Requirements and Specifications
- Results Up Front
- Results Up Front – Master Medications List
- When a doctor tries you on a new medication is it an experiment?
- Experimentation on Human Subjects
- Clozapine Algorithm
- Fleshing Issues by Medication
- E.H.R. Experiment – Increase in Error Rate (Circa 2026)
- Chemically validated diagnoses for mental illness
- Typical Antipsychotics
- Atypical Antipsychotics
- More - How is it that Risperadone and Invega were ineffective for me?
- Fleshing Issues by People (MDs & NPs)
- Brain Games – Reversing or Slowing the Effects of Dementia
- Integrated Circuits to Treat Mental Illness
- Therapeutic changes in brain circuitry and chemistry
- Evolution of ECT
- What is a Chemical Lobotomy?
Results Up Front –
Master Medications List – Part I of II
Not in Chronological Order
Master Medications List – Part II of II
Not in Chronological Order
When a doctor tries you on a new medication is it an experiment?
No, giving you a new medication
is generally not an experiment.
Why It Is
Not an Experiment
Extensive Testing First:
Before a
medication is approved by agencies like the U.S. Food and
Drug Administration (FDA), it undergoes years of laboratory research and Clinical Trials (Phase I–III) involving
thousands of patients to prove it is safe and effective.
Tailored Treatment:
When your
doctor prescribes a new medication, they rely on clinical guidelines, medical
training, and your specific
health history to find the best option for your condition—not to test
an unknown theory on you.
Individual Response:
Every person's
body reacts differently to pharmaceuticals. Adjusting a dose or switching to a
different drug is a process of individualized
fine-tuning, rather than
scientific experimentation.
When
Medication Is
Experimental
A medication is
considered experimental only under specific circumstances:
Clinical Trials:
You are
explicitly enrolled in a structured Clinical
Trials Research Study designed to answer a scientific research question.
Investigational Drugs:
You are taking
a drug that has not yet received regulatory approval and is still being tested
for safety or efficacy, often accessed through specialized trials or expanded
access programs.
Off-Label Use:
A doctor prescribes an already-approved drug for a condition or age group it wasn't originally studied for. While common and legal, this relies on clinical experience rather than primary trial data for that specific use.
Experimentation on Human Subjects
Experiments on human subjects
involve systematic scientific investigations—either interventional or
observational—designed to collect data for medical or social science research.
Core Ethical Principles
Modern human subject research is
guided by strict legal and ethical frameworks to prevent abuse and protect participants:
Voluntary Informed
Consent:
Subjects must
fully understand the nature, risks, and benefits of a study and agree to
participate of their own free will.
Right to Withdraw:
Participants
can leave a study at any time without facing penalties or loss of benefits.
Protection from Harm:
Researchers
must minimize physical, psychological, or social risks.
Institutional Oversight:
Most regulated
research requires approval from an Institutional Review Board
(IRB) or ethics committee before it can begin.
Key Historical Milestones
Global and national guidelines
were shaped largely in response to historical violations:
Nuremberg Code (1947):
Formulated after
World War II in response to Nazi medical atrocities; established the absolute
necessity of voluntary consent.
Declaration of Helsinki
(1964):
Developed by
the World Medical Association as a cornerstone guide for ethical medical
research involving human subjects.
Belmont Report (1978)
& Common Rule (1991):
Set the
foundation for ethical research regulations in the United States, emphasizing
respect for persons, beneficence, and justice.
Notable Examples of Unethical
Experiments
History includes many instances
where ethical principles were severely violated, often targeting prisoners,
soldiers, or marginalized populations without consent:
Nazi Human
Experimentation & Unit 731:
Brutal medical
torture, hypothermia studies, and biological warfare tests conducted during
World War II.
Tuskegee Syphilis Study:
A multi-decade
U.S. Public Health Service study that withheld treatment from Black men with
syphilis without their informed consent.
Project MKUltra:
Clandestine
U.S. CIA experiments involving mind-altering substances like LSD and
psychological interrogation techniques.
Psychological Studies:
Famous social
experiments like the Stanford Prison Experiment and the Milgram obedience experiments raised serious questions about psychological harm and participant
distress.
Clozapine Algorithm
We should have been tried on CloZAPine after 3-4 failures on
anti-psychotics
We were a candidate in the early 1990s yet did not get on it
until 2006
Fleshing Issues by Medication
Common issues and side effects
caused by medicines fall into several main categories, ranging from routine reactions
to severe medical risks.
Common Physical and Digestive
Side Effects
Digestive discomfort:
Nonsteroidal
anti-inflammatory drugs (NSAIDs), antibiotics, and iron supplements can cause
nausea, diarrhea, constipation, gastritis, or stomach ulcers.
Esophageal irritation:
Pills like
aspirin, doxycycline, or vitamin C can stick
in the throat and cause local ulcers or bleeding if swallowed without
enough water.
Drowsiness and dizziness:
Antihistamines,
antidepressants, blood pressure medications, and sleep aids frequently cause fatigue, brain fog, or
lightheadedness.
Balance and fall risks:
Polypharmacy
(taking multiple drugs at once) and high-risk medications like sedatives or
muscle relaxants increase the chance
of falls, especially in older adults.
Drug Interactions
Pharmacokinetic changes:
One drug can
alter how another is processed by the liver or kidneys (for example, grapefruit
juice interacts with statins to raise drug levels in the blood).
Additive or dangerous
effects:
Combining
blood thinners with NSAIDs escalates bleeding risks, while mixing St. John's
wort or herbal supplements with antidepressants can trigger life-threatening serotonin
toxicity.
Severe Allergic and Systemic
Reactions
Severe skin and immune
reactions:
Rare but
life-threatening responses include Anaphylaxis, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and DRESS reaction.
Symptom masking:
Using
over-the-counter or temporary symptom-relief drugs without identifying the root cause can allow underlying diseases to
progress dangerously.
Supply Chain and Manufacturing
Issues
Generic drug quality and
shortages:
A large
portion of generic drug manufacturing occurs overseas, leading to occasional
oversight challenges, contamination risks, and shortages of vital treatments in the United States.
E.H.R. Experiment – Increase in Error Rate (Circa 2026)
Studies show that Electronic
Health Record (EHR) error rates vary widely—ranging from 15% to over 50% depending on
task complexity, vendor design, and workflow delays.
Key Findings on EHR Error
Rates
Operating Room
Documentation:
A recent PMC
study found an overall documentation error rate of 17.01%, surging from 1.30% with no delay to 38.43% for documentation delays exceeding 20 minutes 0.6.1.
Medication Errors:
Research from University of Utah Health revealed that EHR systems fail to detect up to 33% (one in three) of potentially harmful medication errors and drug
interactions.
Task Variability:
A JAMIA study
tracking emergency medicine ordering scenarios across Epic and Cerner systems found error rates reaching up to 50%, with an eightfold difference in required mouse clicks.
Patient-Reported
Mistakes:
In a JAMA
Network Open study, 1 in 5 patients
who read their visit notes reported finding a mistake, with 40% perceiving the error as
serious.
Main Causes of Increased Error
Rates
Documentation Delays:
Rushing to catch up on delayed
charting drastically spikes mistakes during high-intensity procedures.
Information Overload
& Alert Fatigue:
Excessive
notifications, poor interface design, and "note bloat" increase cognitive burden on clinicians.
Local Customization:
Hospitals
often modify software and disable decision-support alerts independently, while
federal regulations typically inspect only baseline
factory software.
Copy-Paste Culture:
Reusing old
text propagates outdated or inaccurate
clinical information across charts.
Chemically validated diagnoses for mental illness
There are no chemically validated (biomarker-based) diagnostic tests used to confirm
mental illnesses.
Clinical Assessment Only:
Psychiatric
diagnoses—such as Major Depressive Disorder, Schizophrenia, Bipolar Disorder, or Anxiety—are
made through clinical interviews,
mental state evaluations, and
standardized criteria like
the DSM-5 rather than blood, urine,
or brain-chemistry assays.
Excluding Physical
Causes:
Lab tests
(such as blood or thyroid panels, drug screens, or imaging) are ordered strictly to rule out
non-psychiatric medical issues (like nutritional deficiencies, neurological
tumors, or autoimmune conditions such as lupus) that can mimic psychiatric symptoms.
The "Chemical
Imbalance" Myth:
The popular idea that mental health disorders are diagnosed or caused by a simple, measurable chemical imbalance in the brain is an oversimplification. While neurotransmitters, inflammation markers, and metabolomics are active areas of research, psychiatry currently relies on a bio-psycho-social model rather than objective chemical tests.
(*) Absolutely miserable medications. Complicated anxiety and sleep issues. Severe adverse reactions including Tardive
Dyskinesia and Muscle Rigidity.
Other Medications
Risperadone (Risperdal) was
ineffective for us. Invega monthly
injection was ineffective for us on two different occasions. It makes sense that Invega would not be
effective. Invega itself is not a metabolite; Invega (brand name for
paliperidone) is already the active form and is the major active metabolite of
the older antipsychotic medication risperidone (Risperdal).
More - How is it that Risperadone and Invega were ineffective for me?
Risperidone and Invega (paliperidone) are chemically almost identical,
meaning that if one does not work for your body, the other is also very likely
to be ineffective. When your body processes risperidone, it
breaks it down into paliperidone, which is the exact active ingredient in
Invega. Because both drugs act on the exact
same brain pathways, they share the same core mechanism. Several biological and clinical factors can
explain why neither medication worked for you.
Shared Pharmacology
The Active Metabolite
Link.
Paliperidone
is the primary active metabolite of risperidone. Taking Invega essentially
skips the liver processing step required by risperidone, delivering the same
active compound directly to your system.
Identical Receptor
Targets.
Both
medications work primarily by blocking specific dopamine (D2) and serotonin
(5-HT2A) receptors in the brain. If your specific symptoms are not driven by
this exact receptor pathway,
neither medication will provide relief.
Individual & Clinical
Factors
Genetic Variations in
Brain Receptors.
Every person
has unique variations in their dopamine and serotonin receptors. Your specific
receptor makeup may simply not
respond well to how these two drugs bind to them.
Diagnosis and Symptom
Mismatch.
While both
medications treat conditions like schizophrenia, they do not target every
symptom type equally. For instance, they are generally less effective for
depressive episodes or negative symptoms like low motivation and emotional
blunting.
Duration Limits.
Antipsychotic
medications often take several weeks
to show their full effect. If treatment was stopped early or adjusted
before reaching a stable regimen, the medication may not have had an adequate
period to work.
Treatment Resistance.
Some
individuals have conditions that do not respond to standard first-line dopamine
blockers. In these cases, a completely different class of medication—such as cloZAPine or newer agents that
target different brain chemicals—is often needed.
What to Discuss With Your
Prescriber
Trying a Different
Chemical Class.
Since both of
these drugs rely on the same compound, ask your doctor about switching to an
antipsychotic with a different chemical
structure and receptor profile.
Reviewing Your Trial
History.
Share the
details of your previous regimens
and how long you took each medication so your doctor can evaluate if you
completed a full clinical trial.
Fleshing Issues by
People (MDs & NPs)
Scored by and for Keith “Buster” Torkelson, MS, BS
(*) Dr. Dobos had bi-weekly
medication management groups which was the most efficient manner to handle a
caseload that we ever experienced.
Unfortunately we went to the hospital on his watch.
(**) These scores will vary
between papers and are subject to change.
Brain Games – Reversing or Slowing the Effects of Dementia
Brain games and cognitive
exercises target specific mental skills like memory, attention,
problem-solving, and speed.
Popular Online Platforms &
Apps
Lumosity:
Features over 40
research-inspired games targeting memory, speed, attention, flexibility, and
problem-solving.
Games for the Brain:
Offers classic browser-based
logic and puzzle games like Sudoku, Chess, Checkers, Reversi, and Mahjongg.
Mind Games:
Provides a free catalog of daily
word searches, nonograms, Sudoku, crosswords, and memory games.
Wordle & Variations:
Daily word puzzles like the
official NYT Wordle or community-favored variations (Quordle, Octordle) help
with vocabulary and pattern recognition.
Classic & Real-World Brain
Games
Number Puzzles:
Sudoku and number sums build
logical thinking and concentration.
Word & Language Games:
Crosswords, Scrabble, Boggle, and
Taboo strengthen verbal fluency and crystallized intelligence.
Strategy & Board Games:
Chess, Checkers, Bridge, Uno, and
Monopoly challenge executive function, working memory, and real-time
problem-solving.
Visuospatial Puzzles:
Jigsaw puzzles,
find-the-difference sheets, and mazes help protect visuospatial functioning as
you age.
Integrated Circuits to Treat Mental Illness
Modern psychiatry increasingly
views mental illness—such as treatment-resistant depression and
obsessive-compulsive disorder (OCD)—not merely as a chemical imbalance, but as
a disorder of brain circuits. Integrated circuits, microchips,
and implantable electronic devices are at the forefront of a shift toward precision neuromodulation.
How Integrated Circuits and
Implants Work in Psychiatry
Deep Brain Stimulation
(DBS):
Involves
surgically implanting miniature electrodes or pacemaker-like devices directly
into specific brain regions (such as the subgenual anterior cingulate cortex).
These integrated systems deliver controlled electrical pulses to modulate and "rewire"
dysfunctional neural networks.
Closed-Loop Systems:
Newer
implantable and wearable technologies are designed to monitor real-time brain
activity and deliver stimulation only when specific biomarker patterns or abnormal
circuit activity are detected.
Targeting Resistant
Conditions:
These hardware
approaches are primarily studied and deployed for patients with severe,
treatment-resistant major depressive disorder (TRD) or debilitating OCD who
have not responded to psychotherapy or multiple medications.
Non-Invasive Alternative
Circuit Therapies
For patients who do not require
or want surgical implants, circuit-level modulation is also achieved via
non-invasive tools:
Transcranial
Magnetic Stimulation (TMS):
Uses external
electromagnetic coils placed on the scalp to stimulate mood-regulating brain
regions like the dorsolateral prefrontal cortex without anesthesia or surgery.
Electroconvulsive Therapy
(ECT):
A
well-established clinical therapy that uses regulated electrical currents under anesthesia to induce therapeutic changes in brain
circuitry and chemistry for severe episodes.
Therapeutic changes in brain circuitry and chemistry
Therapeutic
interventions—including psychotherapy,
pharmacotherapy, and neuromodulation—induce
measurable structural and chemical adaptations in the brain through neuroplasticity.
Changes in
Brain Circuitry (Structure & Activity)
Prefrontal Cortex (PFC):
Talk therapy
and cognitive behavioral approaches strengthen top-down emotional regulation by
increasing functional activity and gray
matter volume in executive control regions.
Amygdala
and Limbic System:
Overactive
alarm centers that drive fear, anxiety, and hyper-reactivity show reduced
baseline volume and decreased hyper-reactivity following successful treatment.
Synaptic
Remodeling:
Interventions
promote the growth of new dendritic
spines and prune outdated
or stress-induced connections,
allowing neural circuits to reorganize.
Targeted
Circuit Stimulation:
Advanced
approaches like Vagus Nerve
Stimulation or deep-brain stimulation directly target specific white-matter
pathways (such as the subcallosal cingulate) to reset malfunctioning loops in
treatment-resistant conditions.
Changes
in Brain Chemistry (Neurotransmitters & HPA Axis)
Serotonin
and Dopamine:
Therapeutic
modalities elevate availability and receptor sensitivity for key
mood-stabilizing and reward-regulating neurotransmitters.
GABA
and Glutamate:
Treatments
enhance inhibitory neurotransmission via GABA
while dialing down excessive excitatory glutamate
and norepinephrine signaling.
BDNF
(Brain-Derived Neurotrophic Factor):
Therapy and
lifestyle interventions trigger BDNF release, which supports the survival of
existing neurons and encourages the growth
of new synapses.
Stress
Hormone Regulation:
Modulating the
hypothalamic-pituitary-adrenal (HPA) axis lowers chronic cortisol output,
protecting the hippocampus from stress-induced
volume loss.
Would you like to explore how a
specific intervention (such as Cognitive Behavioral Therapy,
antidepressants,
or mindfulness)
affects a particular mental health condition?
Evolution of ECT
Electroconvulsive therapy (ECT)
has evolved from a crude, unanesthetized chemical and electrical intervention
into a highly regulated, safe, and precise neuromodulation procedure.
Key Stages of Evolution
Pre-ECT Chemical
Convulsive Era (1930s): The practice grew out of
early theories that induced seizures could alter mental illness. Ladislas
J. Meduna used intramuscular camphor and later Metrazol (cardiazol) to chemically induce seizures in
patients with schizophrenia, though it caused severe pre-seizure panic and high
physical risk.
Invention of Electrical
ECT (1938): Italian psychiatrists Ugo
Cerletti and Lucio
Bini replaced chemical agents with controlled electrical currents delivered
to the scalp, performing the first human ECT treatment in Rome.
The
"Unmodified" Era (1938–1950s):
Early ECT was
administered "unmodified"—meaning without anesthesia or muscle relaxants. High-voltage
alternating currents (AC) induced violent motor convulsions that occasionally
led to bone fractures, dental injuries, and severe post-procedure confusion.
Introduction of
Anesthesia and Muscle Relaxants (1940s–1952):
Wladimir T.
Liberson (1944) shortened stimulus durations, reducing cognitive blunting.
General
anesthesia and barbiturates were introduced for patient comfort.
Paralytic
muscle relaxants—initially curare and later replaced by succinylcholine (1952)—eliminated
violent physical muscle contractions while preserving the therapeutic brain
seizure ("modified ECT").
Refinement of Electrical
Waveforms and Placement (1970s–Present):
Brief-pulse and
ultrabrief-pulse stimuli replaced traditional sine
waves, drastically cutting down memory impairment and cognitive side effects.
Unilateral ECT (applying electrodes to only one hemisphere) was adopted
alongside traditional bilateral placement to further protect memory function.
Modern Status:
Today, ECT is
recognized as a vital, fast-acting treatment for severe, treatment-resistant depression, acute mania,
catatonia, and psychotic depression, backed by safety standards and continuous
innovations like magnetic seizure therapy.
What is a Chemical Lobotomy?
A chemical lobotomy
is a non-medical, descriptive term used to describe the heavy sedation and emotional flattening caused by
certain powerful psychiatric or sedative medications—most historically antipsychotics
like chlorpromazine (Thorazine).
Origins and History
The Rise of
Antipsychotics:
In the early
1950s, the introduction of early antipsychotic drugs like chlorpromazine
revolutionized psychiatric care. Because these drugs rapidly calmed, quieted,
and sedated agitated or psychotic patients without physical surgery, observers
and historians dubbed them a "chemical lobotomy".
Replacing Physical
Surgery:
Before these
medications became widespread, severe mental health conditions were sometimes treated
with physical psychosurgery
(such as standard or transorbital lobotomies) or harsh shocks. Drugs offered a
non-surgical, more predictable way to manage symptoms, though they carried
their own intense sedative and neurological
side effects.
Common Meanings and Contexts
Historical/Medical
Metaphor:
Originally
applied to the first generation of major tranquilizers and antipsychotics that
suppressed acute mania, hallucinations, or severe agitation.
Critiques of Long-Term
Medication:
In modern
discussions, critics, patients, or advocacy groups sometimes use the term
colloquially to describe the side effects of prolonged or high-dose psychiatric
medications (such as antipsychotics, mood stabilizers, or heavy painkillers).
These effects can include:
Emotional
numbing or apathy
Cognitive
dullness or brain fog
Chronic fatigue and physical
sluggishness
Involuntary
movements or tremors



























